322 related articles for article (PubMed ID: 26316440)
1. Nifedipine in Congenital Hyperinsulinism - A Case Report.
Khawash P; Hussain K; Flanagan SE; Chatterjee S; Basak D
J Clin Res Pediatr Endocrinol; 2015 Jun; 7(2):151-4. PubMed ID: 26316440
[TBL] [Abstract][Full Text] [Related]
2. A combination of nifedipine and octreotide treatment in an hyperinsulinemic hypoglycemic infant.
Durmaz E; Flanagan SE; Parlak M; Ellard S; Akcurin S; Bircan I
J Clin Res Pediatr Endocrinol; 2014; 6(2):119-21. PubMed ID: 24932607
[TBL] [Abstract][Full Text] [Related]
3. A Case of Subclinical Hypothyroidism with Lingual and Right Pretracheal Ectopic Thyroid.
Kim MS; Kong YH; Lee DY
J Clin Res Pediatr Endocrinol; 2015 Jun; 7(2):148-50. PubMed ID: 26316439
[TBL] [Abstract][Full Text] [Related]
4. Novel mutation c.597_598dup in exon 5 of ABCC8 gene causing congenital hyperinsulinism.
Jindal R; Ahmad A; Siddiqui MA; Kochar IS; Wangnoo SK
Diabetes Metab Syndr; 2014; 8(1):45-7. PubMed ID: 24661758
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Nifedipine Therapy in Hyperinsulinemic Hypoglycemia due to Mutations in the ABCC8 Gene.
Güemes M; Shah P; Silvera S; Morgan K; Gilbert C; Hinchey L; Hussain K
J Clin Endocrinol Metab; 2017 Mar; 102(3):822-830. PubMed ID: 27898257
[TBL] [Abstract][Full Text] [Related]
6. Monoallelic ABCC8 mutations are a common cause of diazoxide-unresponsive diffuse form of congenital hyperinsulinism.
Saint-Martin C; Zhou Q; Martin GM; Vaury C; Leroy G; Arnoux JB; de Lonlay P; Shyng SL; Bellanné-Chantelot C
Clin Genet; 2015 May; 87(5):448-54. PubMed ID: 24814349
[TBL] [Abstract][Full Text] [Related]
7. Congenital hyperinsulinism due to compound heterozygous mutations in ABCC8 responsive to diazoxide therapy.
Taylor-Miller T; Houghton J; Munyard P; Kumar Y; Puvirajasinghe C; Giri D
J Pediatr Endocrinol Metab; 2020 May; 33(5):671-674. PubMed ID: 32267248
[TBL] [Abstract][Full Text] [Related]
8. Characterization of diabetes following pancreatic surgery in patients with congenital hyperinsulinism.
Welters A; Meissner T; Grulich-Henn J; Fröhlich-Reiterer E; Warncke K; Mohnike K; Blankenstein O; Menzel U; Datz N; Bollow E; Holl RW
Orphanet J Rare Dis; 2018 Dec; 13(1):230. PubMed ID: 30577875
[TBL] [Abstract][Full Text] [Related]
9. Conservatively treated Congenital Hyperinsulinism (CHI) due to K-ATP channel gene mutations: reducing severity over time.
Salomon-Estebanez M; Flanagan SE; Ellard S; Rigby L; Bowden L; Mohamed Z; Nicholson J; Skae M; Hall C; Craigie R; Padidela R; Murphy N; Randell T; Cosgrove KE; Dunne MJ; Banerjee I
Orphanet J Rare Dis; 2016 Dec; 11(1):163. PubMed ID: 27908292
[TBL] [Abstract][Full Text] [Related]
10. A novel mutation in ABCC8 gene in a newborn with congenital hyperinsulinism -a case report.
Üstün NU; Dilli D; Kundak AA; Okumus N; Erdoğan D; Apaydın S
Fetal Pediatr Pathol; 2013 Dec; 32(6):412-7. PubMed ID: 23607867
[TBL] [Abstract][Full Text] [Related]
11. Sirolimus in the treatment of three infants with diffuse congenital hyperinsulinism.
Al-Balwi R; Al-Atawi M; Al-Otaibi A; Babiker O; Al-Mutair A
J Pediatr Endocrinol Metab; 2017 Aug; 30(9):1013-1017. PubMed ID: 28787272
[TBL] [Abstract][Full Text] [Related]
12. Clinical Management and Gene Mutation Analysis of Children with Congenital Hyperinsulinism in South China.
Xu A; Cheng J; Sheng H; Wen Z; Lin Y; Zhou Z; Zeng C; Shao Y; Li C; Liu L; Li X
J Clin Res Pediatr Endocrinol; 2019 Nov; 11(4):400-409. PubMed ID: 31208162
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics, outcome, and predictors of neurological sequelae of persistent congenital hyperinsulinism: A single tertiary center experience.
Laimon W; Aboelenin HM; El Tantawi NT
Pediatr Diabetes; 2021 May; 22(3):388-399. PubMed ID: 33528087
[TBL] [Abstract][Full Text] [Related]
14. Octreotide-related exocrine pancreatic insufficiency (EPI) in congenital hyperinsulinism.
Ros-Pérez P; Golmayo L; Cilleruelo ML; Gutiérrez C; Celaya P; Lacámara N; Martínez-Badás I; Güemes M; Argente J
J Pediatr Endocrinol Metab; 2020 Jul; 33(7):947-950. PubMed ID: 32634108
[TBL] [Abstract][Full Text] [Related]
15. Sirolimus Therapy and Follow-up in a Patient with Severe Congenital Hyperinsulinism Following Subtotal Pancreatectomy.
Chen Q; Chen Y; Wang X; Yang H; Zhang Y; Liu X; Yan Y; Wei H
J Clin Res Pediatr Endocrinol; 2021 Feb; 13(1):119-123. PubMed ID: 32482020
[TBL] [Abstract][Full Text] [Related]
16. Clinical and genetic characteristics of patients with congenital hyperinsulinism in 21 non-consanguineous families from Serbia.
Raicevic M; Milenkovic T; Hussain K; Djordjevic M; Martic J; Todorovic S; Mitrovic K; Sarajlija A; Vukovic R
Eur J Pediatr; 2021 Sep; 180(9):2815-2821. PubMed ID: 33770274
[TBL] [Abstract][Full Text] [Related]
17. Clinical presentation and treatment response to diazoxide in two siblings with congenital hyperinsulinism as a result of a novel compound heterozygous ABCC8 missense mutation.
Galcheva S; Iotova V; Ellard S; Flanagan SE; Halvadzhiyan I; Petrova C; Hussain K
J Pediatr Endocrinol Metab; 2017 Apr; 30(4):471-474. PubMed ID: 28328534
[TBL] [Abstract][Full Text] [Related]
18. An Egyptian case of congenital hyperinsulinism of infancy due to a novel mutation in KCNJ11 encoding Kir6.2 and response to octreotide.
Sherif EM; Abdelmaksoud AA; Elbarbary NS; Njølstad PR
Acta Diabetol; 2013 Oct; 50(5):801-5. PubMed ID: 20686794
[TBL] [Abstract][Full Text] [Related]
19. Therapies and outcomes of congenital hyperinsulinism-induced hypoglycaemia.
Banerjee I; Salomon-Estebanez M; Shah P; Nicholson J; Cosgrove KE; Dunne MJ
Diabet Med; 2019 Jan; 36(1):9-21. PubMed ID: 30246418
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and phenotype-genotype analysis in Turkish patients with congenital hyperinsulinism; predominance of recessive KATP channel mutations.
Demirbilek H; Arya VB; Ozbek MN; Akinci A; Dogan M; Demirel F; Houghton J; Kaba S; Guzel F; Baran RT; Unal S; Tekkes S; Flanagan SE; Ellard S; Hussain K
Eur J Endocrinol; 2014 Jun; 170(6):885-92. PubMed ID: 24686051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
